InvestorsHub Logo
Replies to #75788 on Biotech Values
icon url

cvsnumber1

04/12/09 1:39 PM

#75793 RE: DewDiligence #75788

Dew, did you get a chance to listen to the Lazard Cleveland
clinic call. Joel Sendek is a complete idiot. If you did
how could you not think the DNDN folks have a slight right to
be upset. This is a quote from Sendek straight from the call
"Lead PI said that Provenge effect was a hallucination and
same Doc says Abiraterone is the holy grail." Sendek's
questions on all the calls I've heard him on are quite
simple and he seems to lack a very basic knowledge of anything
needed for an adequate biotech analyst. He has been corrected
on calls several times by DNDN management and on many other
CC he has participated in.
icon url

exwannabe

04/12/09 7:53 PM

#75807 RE: DewDiligence #75788

Re; CGRB/DNDN

"The DNDN loonies are certain that the abiraterone program is a conspiracy to deny Provenge its rightful place in the prostate-cancer pecking order."

Given that abiraterone is hitting the hormone pathways for PC it would seam likely to have little to no effect on Provenge uptake (which hopefully would be used concurrently with hormone therapy after radiation/surgery).

I do think it has taken over from Provenge for it's place on the PC over-hyped list though :-)